\ua9 2022 The Author(s). Published by Oxford University Press on behalf of European Crohn\u27s and Colitis Organisation. Background and Aims: Inflammatory bowel diseases [IBD] have a complex polygenic aetiology. Rare genetic variants can cause monogenic intestinal inflammation. The impact of chromosomal aberrations and large structural abnormalities on IBD susceptibility is not clear. We aimed to comprehensively characterise the phenotype and prevalence of patients with IBD who possess rare numerical and structural chromosomal abnormalities. Methods: We performed a systematic literature search of databases PubMed and Embase; and analysed gnomAD, Clinvar, the 100 000 Genomes Project, and DECIPHER databases. Further, we analysed international...
Background: Family studies support a genetic predisposition to inflammatory bowel diseases (IBD), bu...
The chronic inflammatory bowel diseases (IBDs)—Crohn disease (CD) and ulcerative colitis (UC)—are id...
BACKGROUND & AIMS: A proportion of infants and young children with inflammatory bowel diseases (IBDs...
Background and Aims Inflammatory bowel diseases [IBD] have a complex polygenic aetiology. Rare genet...
SummaryInflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammat...
Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, ty...
The contribution of rare coding sequence variants to genetic susceptibility in complex disorders is ...
Author Summary Crohn's disease and ulcerative colitis are two forms of inflammatory bowel disease wh...
For over two decades, the study of genetics has been making significant progress towards understandi...
Background and Aims Although genome-wide association studies [GWAS] in inflammatory bowel disease [...
Inflammatory bowel disease (IBD) is a complex disorder of unknown etiology. Epidemiological investig...
Currently, the best clinical predictor for inflammatory bowel disease (IBD) is family history. Over ...
To further resolve the genetic architecture of the inflammatory bowel diseases ulcerative colitis an...
12Background: Inflammatory bowel diseases (IBDs) are complex, multifactorial disorders that comprise...
Background & Aims: A proportion of infants and young children with inflammatory bowel diseases (IBDs...
Background: Family studies support a genetic predisposition to inflammatory bowel diseases (IBD), bu...
The chronic inflammatory bowel diseases (IBDs)—Crohn disease (CD) and ulcerative colitis (UC)—are id...
BACKGROUND & AIMS: A proportion of infants and young children with inflammatory bowel diseases (IBDs...
Background and Aims Inflammatory bowel diseases [IBD] have a complex polygenic aetiology. Rare genet...
SummaryInflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammat...
Inflammatory bowel disease (IBD) is characterized by a chronic relapsing intestinal inflammation, ty...
The contribution of rare coding sequence variants to genetic susceptibility in complex disorders is ...
Author Summary Crohn's disease and ulcerative colitis are two forms of inflammatory bowel disease wh...
For over two decades, the study of genetics has been making significant progress towards understandi...
Background and Aims Although genome-wide association studies [GWAS] in inflammatory bowel disease [...
Inflammatory bowel disease (IBD) is a complex disorder of unknown etiology. Epidemiological investig...
Currently, the best clinical predictor for inflammatory bowel disease (IBD) is family history. Over ...
To further resolve the genetic architecture of the inflammatory bowel diseases ulcerative colitis an...
12Background: Inflammatory bowel diseases (IBDs) are complex, multifactorial disorders that comprise...
Background & Aims: A proportion of infants and young children with inflammatory bowel diseases (IBDs...
Background: Family studies support a genetic predisposition to inflammatory bowel diseases (IBD), bu...
The chronic inflammatory bowel diseases (IBDs)—Crohn disease (CD) and ulcerative colitis (UC)—are id...
BACKGROUND & AIMS: A proportion of infants and young children with inflammatory bowel diseases (IBDs...